Holen Sie sich die Stockscreener-App
0.384
0.21%
-0.0008
Handel nachbörslich:
.39
0.006
+1.56%
Schlusskurs vom Vortag:
$0.3848
Offen:
$0.38
24-Stunden-Volumen:
107.68K
Relative Volume:
0.03
Marktkapitalisierung:
$10.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.29M
KGV:
-8.3843
EPS:
-0.0458
Netto-Cashflow:
$-9.72M
1W Leistung:
-1.54%
1M Leistung:
+34.08%
6M Leistung:
-95.53%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.38
$0.41
1-Wochen-Bereich:
$0.3701
$0.50
52-Wochen-Spanne:
$0.262
$9.1796
Curanex Pharmaceuticals Inc Stock (CURX) Company Profile
Firmenname
Curanex Pharmaceuticals Inc
Sektor
Branche
Telefon
718-673-6078
Adresse
2 JERICHO PLAZA,, JERICHO
Compare CURX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CURX
Curanex Pharmaceuticals Inc
|
0.384 | 10.91M | 0 | -1.29M | -9.72M | -0.0458 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Curanex Pharmaceuticals Inc Aktie (CURX) Neueste Nachrichten
Curanex adds two advisors to scientific board ahead of IND filing By Investing.com - Investing.com India
Curanex adds two advisors to scientific board ahead of IND filing - Investing.com South Africa
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers - The Manila Times
TB and COVID scientists join Curanex board to steer 2026 trial plans - Stock Titan
Curanex adds two pharmaceutical veterans to advisory board - Investing.com India
Curanex adds two pharmaceutical veterans to advisory board By Investing.com - Investing.com Nigeria
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board - Yahoo Finance Singapore
Curanex Formalizes Long-Term Executive Employment and Compensation Agreements - TipRanks
Curanex Pharmaceuticals Inc Enters into Executive Employment Agreement with Jun Liu as President and Chairman of the Board, Effective March 1, 2026 - marketscreener.com
Curanex Forms World Class Scientific Advisory Board - Bitget
Botanical drug firm Curanex taps Fortune 100 pharma exec to guide R&D - Stock Titan
Curanex Pharmaceuticals Inc (CURX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stocks in the News: ALBT, NDRA, CURX, HCTIAI, Clinical Milestones Drive Market Surges - marketscreener.com
Market Movers | Winners: IXHL, ALBT, RXT | Losers: THRY, EOSE, ERII - Trefis
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's session: most active stocks - ChartMill
Unusual volume stocks are being observed in Thursday's session. - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Curanex Pharmaceuticals Stock Soars 56.32% After Key IND Milestone - Intellectia AI
24,000,000 Common Stock of Curanex Pharmaceuticals Inc are subject to a Lock-Up Agreement Ending on 26-FEB-2026. - marketscreener.com
Curanex Pharmaceuticals IncCommon Stock (Nasdaq:CURX) Stock Quote - The Chronicle-Journal
Top movers in Wednesday's after hours session - ChartMill
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Curanex completes GMP pilot batch for ulcerative colitis drug - Investing.com
Curanex Completes GMP Pilot For Phyto-N, Targets IND Submission In Ulcerative Colitis - Nasdaq
Curanex provides operational update on key regulatory milestones - marketscreener.com
Curanex completes GMP pilot batch for ulcerative colitis drug By Investing.com - Investing.com South Africa
Curanex Provides Operational Update on Key Regulatory Milestones - GlobeNewswire
Comparing Curanex Pharmaceuticals (CURX) & The Competition - Defense World
Curanex Pharmaceuticals (CURX) versus Its Peers Financial Survey - Defense World
Financial Contrast: Curanex Pharmaceuticals (CURX) & Its Peers - Defense World
Curanex Pharmaceuticals appoints new chief financial officer - MSN
Contrasting Curanex Pharmaceuticals (CURX) and The Competition - Defense World
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation By Investing.com - Investing.com Nigeria
Curanex Pharmaceuticals appoints Wanjun Zhang as CFO following resignation - Investing.com
Curanex Pharmaceuticals (CURX) Competitors and Alternatives 2026 - MarketBeat
Curanex Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
Curanex Pharmaceuticals Announces CFO Transition - TradingView — Track All Markets
Curanex Pharmaceuticals Inc Announces Executive Changes - marketscreener.com
Curanex Pharmaceuticals announces pricing of its initial public offering - MSN
Finanzdaten der Curanex Pharmaceuticals Inc-Aktie (CURX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):